Text logo reading KWEHEALTH with the A represented by a bold, red, slanted line and black vertical line, contrasting against the white background.

Characterizing Exosomes Using Next-Gen Protein Sequencing

Dive into this case study to see how KWEHealth is exploring cutting-edge technologies to advance exosome-based therapeutics. They view next-gen protein sequencing (NGPS) as a game-changer and are leveraging its capabilities to drive progress in their research. Learn how NGPS is shaping their approach.